TY - JOUR
T1 - Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes
AU - Casiano, Carlos A.
AU - Ochs, Robert L.
AU - Tan, Eng M.
N1 - Funding Information:
We thank Drs K Michael Pollard (The Scripps Research Institute, La Jolla), Martin Blüthner (University of Heidelberg, Germany), Guy Salvesen (The Burnham Institute, La Jolla), Seamus J Martin (Maynooth College, Ireland) and Douglas R Green (La Jolla Institute for Allergy and Immunology) for valuable discussions and suggestions. This work was supported by grants from the National Institutes of Health. CAC was supported in part by a Postdoctoral Fellowship Award from the Arthritis Foundation. This is publication number 10638-MEM from The Scripps Research Institute.
PY - 1998/2
Y1 - 1998/2
N2 - A central mechanism in apoptosis is the activation of proteases of the caspase (cysteine aspartases) family. Protease activation has also been implicated in necrosis, but its role in this cell death process and the identity of the proteases involved and their substrates, are unknown. Using human autoantibodies to well characterized cellular proteins as detecting probes in immunoblotting, we observed that a defined and somewhat similar set of nuclear proteins, including poly (ADP-ribose) polymerase (PARP) and DNA topoisomerase I (Topo I), were selectively cleaved during both apoptosis and necrosis of cultured cells induced by various stimuli. The resulting cleavage products were distinctively different in the two cell death pathways. In contrast to apoptosis, the cleavages of PARP and Topo I during necrosis were not blocked by the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk). These findings suggest that different proteases act in apoptosis and necrosis, and that although both cell death processes result in selective cleavage of almost identical cellular proteins, they can be distinguished immunochemically on the basis of their cleavage products.
AB - A central mechanism in apoptosis is the activation of proteases of the caspase (cysteine aspartases) family. Protease activation has also been implicated in necrosis, but its role in this cell death process and the identity of the proteases involved and their substrates, are unknown. Using human autoantibodies to well characterized cellular proteins as detecting probes in immunoblotting, we observed that a defined and somewhat similar set of nuclear proteins, including poly (ADP-ribose) polymerase (PARP) and DNA topoisomerase I (Topo I), were selectively cleaved during both apoptosis and necrosis of cultured cells induced by various stimuli. The resulting cleavage products were distinctively different in the two cell death pathways. In contrast to apoptosis, the cleavages of PARP and Topo I during necrosis were not blocked by the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk). These findings suggest that different proteases act in apoptosis and necrosis, and that although both cell death processes result in selective cleavage of almost identical cellular proteins, they can be distinguished immunochemically on the basis of their cleavage products.
KW - Apoptosis
KW - Autoantibodies
KW - Necrosis
KW - Nuclear proteins
KW - Proteases
UR - http://www.scopus.com/inward/record.url?scp=0031819578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031819578&partnerID=8YFLogxK
U2 - 10.1038/sj.cdd.4400336
DO - 10.1038/sj.cdd.4400336
M3 - Article
C2 - 10200463
SN - 1350-9047
VL - 5
SP - 183
EP - 190
JO - Cell Death and Differentiation
JF - Cell Death and Differentiation
IS - 2
ER -